RXFP2

relaxin family peptide receptor 2, the group of Relaxin family peptide receptors

Basic information

Region (hg38): 13:31739525-31803389

Previous symbols: [ "LGR8" ]

Links

ENSG00000133105NCBI:122042OMIM:606655HGNC:17318Uniprot:Q8WXD0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • cryptorchidism (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
CryptorchidismADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingGenitourinary12217959; 12970298

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RXFP2 gene.

  • Bilateral cryptorchidism (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RXFP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
missense
1
clinvar
37
clinvar
6
clinvar
1
clinvar
45
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
1
1
non coding
27
clinvar
27
Total 1 1 37 6 33

Variants in RXFP2

This is a list of pathogenic ClinVar variants found in the RXFP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
13-31739639-T-A not specified Uncertain significance (Mar 30, 2024)3315838
13-31739653-G-C not specified Uncertain significance (Apr 09, 2024)3315840
13-31739671-T-G not specified Uncertain significance (Jan 04, 2024)3157282
13-31739685-A-G not specified Uncertain significance (Jun 09, 2022)2374795
13-31757975-T-C Benign (Jun 19, 2021)1257281
13-31758080-G-A Benign (Jun 19, 2021)1294621
13-31758155-C-G Benign (Jun 20, 2021)1239108
13-31758267-T-C not specified Uncertain significance (Apr 08, 2024)3315839
13-31758273-A-C not specified Uncertain significance (Sep 13, 2023)2623816
13-31758288-C-T not specified Uncertain significance (Jun 16, 2024)3315844
13-31758296-T-C not specified Uncertain significance (Apr 26, 2023)2540987
13-31758378-G-A not specified Uncertain significance (Apr 07, 2022)2282343
13-31758383-G-A not specified Uncertain significance (Sep 16, 2021)2221905
13-31758390-A-G not specified Uncertain significance (Mar 20, 2023)2526833
13-31758400-C-A not specified Uncertain significance (Jun 23, 2021)2233110
13-31758400-C-G not specified Uncertain significance (Mar 29, 2022)2280637
13-31758419-C-T Benign (Nov 12, 2018)1229034
13-31758524-T-C Benign (Nov 12, 2018)1283483
13-31758543-T-C Benign (Jun 19, 2021)1277268
13-31761703-A-T Benign (Nov 12, 2018)1268067
13-31761733-G-A not specified Uncertain significance (Aug 31, 2022)2309936
13-31761742-C-T not specified Uncertain significance (Oct 26, 2022)2381466
13-31761743-G-A Benign (Jun 09, 2021)1233360
13-31761903-C-T Benign (Jun 19, 2021)1226064
13-31764707-TACTC-T Benign (Jun 19, 2021)1239917

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RXFP2protein_codingprotein_codingENST00000298386 1863336
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
9.90e-160.41412563101171257480.000465
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8943453950.8730.00001975002
Missense in Polyphen82108.740.75411418
Synonymous0.2341401440.9750.000008021382
Loss of Function1.542939.40.7360.00000206481

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009620.000962
Ashkenazi Jewish0.0003000.000298
East Asian0.001250.00125
Finnish0.00009240.0000924
European (Non-Finnish)0.0005030.000501
Middle Eastern0.001250.00125
South Asian0.0001310.000131
Other0.0003290.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for relaxin. The activity of this receptor is mediated by G proteins leading to stimulation of adenylate cyclase and an increase of cAMP. May also be a receptor for Leydig insulin-like peptide (INSL3).;
Pathway
Relaxin signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Myometrial Relaxation and Contraction Pathways;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Relaxin receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.126

Intolerance Scores

loftool
0.569
rvis_EVS
-0.18
rvis_percentile_EVS
40.56

Haploinsufficiency Scores

pHI
0.166
hipred
N
hipred_score
0.280
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0535

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rxfp2
Phenotype
hematopoietic system phenotype; reproductive system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
oocyte maturation;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;negative regulation of cell population proliferation;male gonad development;hormone-mediated signaling pathway;negative regulation of apoptotic process;positive regulation of cAMP-mediated signaling
Cellular component
plasma membrane;integral component of plasma membrane
Molecular function
G protein-coupled peptide receptor activity;protein-hormone receptor activity;peptide hormone binding